Sales for the quarter ended at MNOK 67.4 (MNOK 74.6). Sales
for 2016 ended at MNOK 268.1 (MNOK 251.4), a growth of 6.6 %.
For the year 20 MNOK of sales is lost related to the
Medtronic products. Currency neutral sales of own products
decreased with 3 MNOK or 5.7 % and was influenced by a back
order situation for the flow probes. For the year currency
neutral sales of own products increased with 9.5 %.
Operating profit (EBIT) for the quarter ended at MNOK 9.7
(MNOK 16.0). Operating profit for 2016 ended at MNOK 56.4
(MNOK 50.3). The Board suggests a dividend of NOK 1.75 per
share (NOK 1.65).
Continued strong development in the US where currency
neutral growth in sales was 13.4 %. For 2016 currency
neutral growth was 14.2 % .
Medistim launch of the New SonoQ product in India in the
fourth quarter.